Home Cart Sign in  
Chemical Structure| 49607-15-0 Chemical Structure| 49607-15-0

Structure of 49607-15-0

Chemical Structure| 49607-15-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 49607-15-0 ]

CAS No. :49607-15-0
Formula : C8H10N2O3
M.W : 182.18
SMILES Code : NCCC1=CC([N+]([O-])=O)=C(C=C1)O
MDL No. :MFCD00238620
InChI Key :IUCYCHQMRZWPGT-UHFFFAOYSA-N
Pubchem ID :18958330

Safety of [ 49607-15-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Computational Chemistry of [ 49607-15-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 3
Num. H-bond acceptors 4.0
Num. H-bond donors 2.0
Molar Refractivity 49.77
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

92.07 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.31
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.33
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.8
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.11
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.86
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.54

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.95
Solubility 2.04 mg/ml ; 0.0112 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.86
Solubility 0.249 mg/ml ; 0.00137 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.65
Solubility 4.04 mg/ml ; 0.0222 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.47 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.71

Application In Synthesis of [ 49607-15-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 49607-15-0 ]

[ 49607-15-0 ] Synthesis Path-Downstream   1~9

  • 1
  • [ 51-67-2 ]
  • [ 49607-15-0 ]
  • 4-(2-amino-ethyl)-2,6-dinitro-phenol [ No CAS ]
  • 2
  • [ 49607-15-0 ]
  • [ 81666-88-8 ]
YieldReaction ConditionsOperation in experiment
84% With hydrogen iodide; hypophosphorous acid; for 1.0h;Reflux; General procedure: The nitrophenol compounds 8b?13b were then heated under reflux with 57percent HI (10 mL) in thepresence of 30percent H3PO2 (1.0 mL). After 60 min, HPLC analysis confirmed the absence of the nitratedcompounds and the appearance of products corresponding most likely to amino derivatives resultingfrom reduction to amine at the o- (and p-) positions of the hydroxy group. The mixture was evaporated to dryness, taken up in 0.1 M HCl (3 mL) and chromatographed on a Dowex 50W-X2 (200?400 mesh)column (1.8 cm × 31 cm, equilibrated and eluted with 2 M HCl). Fractions of 20 mL were collectedand analyzed by UV spectrophotometry (200?400 nm) and by HPLC. The analytical conditions ofHPLC are described in Section 3.2. After fractions of the target compound were collected,recrystallization of compounds 8c?13c from ethanol (5 mL) plus ether (25 mL) and compound 14cfrom 6 M HCl (3 mL) plus acetone (60 mL) gave colorless crystals as HCl salts.
  • 3
  • [ 51-67-2 ]
  • [ 7697-37-2 ]
  • [ 49607-15-0 ]
  • 4-(2-amino-ethyl)-2,6-dinitro-phenol [ No CAS ]
  • 4
  • [ 51-67-2 ]
  • [ 49607-15-0 ]
YieldReaction ConditionsOperation in experiment
90.3% With nitric acid; In water; at 20℃; for 0.166667h; General procedure: An appropriate phenol compound 8a?13a (1 mmol) was mixed with 60percent HNO3 (4.8 mmol). Theresulting suspension was stirred at room temperature for 10 min for 8a and 9a, for 30 min for 10a, 12aand 13a, or overnight for 11a, leading eventually to an intensively dark red solution. HPLC analysisconfirmed the absence of starting material and the presence of 3 major products corresponding mostlikely to nitro derivatives resulting from nitration at the o- and p-positions of the hydroxy group fromthe m-substituted phenols 8a, 10a and 12a, but only one product from the p-substituted phenols 9a,11a and 13a. The crude nitrophenol 8b or 9b was diluted with water (20 mL) and applied onto aDowex 50W-X2 (200?400 mesh) column (1.5 cm × 6 cm, H+ form, equilibrated with water).The column was washed with water (100 mL) and then the product was eluted with 2 M HCl(20 mL/fraction). Fractions containing the target compound were combined and evaporated to drynessto give a yellow powder. After the nitration of phenols 10a, 12a and 13a, the reaction mixture (10b,12b and 13b) was diluted with H2O (20 mL) and extracted with ethyl acetate (2 × 100 mL). Thecombined organic extract was washed with water (2 × 50 mL), dried with Na2SO4 and evaporatedunder reduced pressure. The nitration of 11a afforded 11b as an orange powder in the reaction mixture.After the filtration, the powder was washed with water and dried under reduced pressure to give a darkred powder 11b.
34% With nitric acid; In water; at 0 - 20℃; for 0.166667h; [0228] Synthesis of o-nitrotyramine (S5). This procedure was adapted from Waser and Sommer {Helv. Chim. Acta 1923, 6, 54-61). Tyramine (0.57 g, 4.16 mmol, 1 eq.) in 4 mL of water in a 20 mL scintillation vial was cooled to 0 °C with an ice bath. Nitric acid (2 ml) was added dropwise, and the solution turned reddish brown immediately. After the addition, the reaction was warmed to room temperature and stirred for 10 min. The reaction mixture then stood uncovered at room temperature overnight, at which point the yellow precipitate was collected with a Biichner funnel. This crude product was recrystallized from 3-5 mL of boiling water to afford 0.25 g of papery yellow material (34percent).
  • 5
  • [ 49607-15-0 ]
  • [ 100-39-0 ]
  • [ 49640-22-4 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In dimethyl sulfoxide; EXAMPLE 1 A solution of 17.1 g. (0.1 m.) of benzyl bromide in 100 ml. of dimethylsulfoxide is added slowly to a stirred mixture of 18.2 g. (0.1 m.) of 4-hydroxy-3-nitrophenethylamine in 1 l. of dimethylsulfoxide and 60 ml. of 2N sodium hydroxide at 85°C. After addition is complete the reaction mixture is stirred at 85°C. for an additional two hours, poured into ice-water, saturated with sodium chloride and extracted with ethyl acetate. The organic extract is dried and concentrated to give 4-benzyloxy-3-nitrophenethylamine.
  • 6
  • [ 49607-15-0 ]
  • oregon green 514 o-aminophenol [ No CAS ]
  • 7
  • [ 49607-15-0 ]
  • oregon green 514 NHS-ester [ No CAS ]
  • oregon green 514 o-nitrophenol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In N,N-dimethyl-formamide; for 0.5h; [0229] Synthesis of Oregon green 514 o-nitrophenol (S6). Oregon green 514 NHS-ester (2.46 mg, 0.004 mmol, 1 eq.) was dissolved in 1 mL of DMF. Compound S5 (1.31 mg, 0.0097 mmol, 2.4 eq.) and triethylamine (8.15 mg, 0.081 mmol, 20 eq.) were added and the reaction was turned end-over-end for 30 min on a laboratory rotisserie. The solvent was removed under reduced pressure, and the crude product mixture was dissolved in 250 °L of methanol. After filtration through a 0.2 mupiiota filter, the o-nitrophenol product was purified via HPLC using an Alltech Econosil CI 8 10 mupiiota column with a gradient of 5-95percent acetonitrile in water with 0.1percent TFA over 1 h. The solvent was removed under reduced pressure, and the dye was stored as a 5 mM solution in 50 iL of DMSO.
  • 8
  • [ 60-19-5 ]
  • [ 49607-15-0 ]
  • 9
  • [ 108-31-6 ]
  • [ 49607-15-0 ]
  • C12H10N2O5 [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 49607-15-0 ]

Aryls

Chemical Structure| 4920-77-8

A143425 [4920-77-8]

2-Nitro-3-methylphenol

Similarity: 0.87

Chemical Structure| 13073-29-5

A100980 [13073-29-5]

2-Methyl-6-nitrophenol

Similarity: 0.87

Chemical Structure| 3272-08-0

A144164 [3272-08-0]

4-Hydroxy-3-nitrobenzonitrile

Similarity: 0.82

Chemical Structure| 3163-07-3

A185025 [3163-07-3]

4-Nitrobenzene-1,3-diol

Similarity: 0.81

Chemical Structure| 2581-34-2

A155333 [2581-34-2]

3-Methyl-4-nitrophenol

Similarity: 0.80

Amines

Chemical Structure| 16292-88-9

A218754 [16292-88-9]

3-Methoxy-4-nitroaniline

Similarity: 0.79

Chemical Structure| 115287-37-1

A124477 [115287-37-1]

N-Methyl-2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine

Similarity: 0.74

Chemical Structure| 55730-09-1

A101329 [55730-09-1]

4-Methoxy-5-methyl-2-nitroaniline

Similarity: 0.73

Chemical Structure| 86771-76-8

A189422 [86771-76-8]

5-Methoxy-4-methyl-2-nitroaniline

Similarity: 0.73

Chemical Structure| 16554-47-5

A272236 [16554-47-5]

3-Methoxy-2-nitroaniline

Similarity: 0.73

Nitroes

Chemical Structure| 4920-77-8

A143425 [4920-77-8]

2-Nitro-3-methylphenol

Similarity: 0.87

Chemical Structure| 13073-29-5

A100980 [13073-29-5]

2-Methyl-6-nitrophenol

Similarity: 0.87

Chemical Structure| 3272-08-0

A144164 [3272-08-0]

4-Hydroxy-3-nitrobenzonitrile

Similarity: 0.82

Chemical Structure| 3163-07-3

A185025 [3163-07-3]

4-Nitrobenzene-1,3-diol

Similarity: 0.81

Chemical Structure| 2581-34-2

A155333 [2581-34-2]

3-Methyl-4-nitrophenol

Similarity: 0.80